+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization



A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization



Japanese Journal of Clinical Oncology 27(5): 331-335



The prognosis of patients with unresectable liver metastases is poor, even if hepatic arterial infusion chemotherapy (HAI) or systemic chemotherapy is administered. A pilot study was performed to evaluate the feasibility and efficacy of multimodality therapy with hepatectomy after HAI and portal embolization for such patients. Eight patients with colorectal carcinoma and synchronous unresectable liver metastases underwent resection of the primary tumor and placement of a pump, followed by HAI with 5-fluorouracil and mitomycin C. Owing to shrinkage of the liver metastases, two patients could undergo extended right hepatic lobectomy after portal embolization, which was deemed to be essential to prevent post-operative hepatic failure. The median survival time of the eight patients was 30 months, with a response rate of 75%. Complications including sclerosing cholangitis and duodenal ulcer were observed in five patients (63%). Additional hepatectomy could be performed successfully after portal embolization without morbidity in two patients. These two patients are still alive more than 6 years after initiation of HAI and have been free of disease for more than 5 years after hepatectomy. Hepatectomy after HAI and portal embolization is feasible and may be an option to cure selected patients with initially unresectable liver metastases.

(PDF emailed within 0-6 h: $19.90)

Accession: 009753803

Download citation: RISBibTeXText

PMID: 9390211

DOI: 10.1093/jjco/27.5.331


Related references

Long-term results of hepatectomy after hepatic arterial infusion chemotherapy for initially unresectable hepatic colorectal metastases. Journal of Gastrointestinal Surgery 13(9): 1643-1650, 2009

Conversion chemotherapy followed by hepatic resection in colorectal cancer with initially unresectable liver-limited metastases. Oncology Reports 30(6): 2992-2998, 2014

Clinical results of pharmacokinetic modulating chemotherapy (PMC) in combination with hepatic arterial 5FU infusion, continuous venous 5FU infusion and oral UFT as adjuvant chemotherapy after liver resection for hepatic colorectal metastases. Journal of Clinical Oncology 23(16_suppl): 3665-3665, 2016

Hepatic resection after neoadjuvant therapy for initially unresectable colorectal liver metastases. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(13): 2579-2582, 2010

Evaluation of hepatic resection following hepatic arterial infusion chemotherapy for colorectal liver metastases. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(12): 1826-1829, 2000

A case of unresectable multiple liver metastases from colon cancer successfully treated by hepatic arterial infusion chemotherapy and systemic immunotherapy (IFNANK) followed by hepatic resection. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1812-1814, 2004

Indication for hepatic resection after hepatic arterial infusion chemotherapy for multiple liver metastases of colorectal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(12): 1834-1837, 2000

Indication of prophylactic hepatic arterial-infusion chemotherapy after hepatic resection for liver metastases from colorectal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(11): 1457-1460, 1996

Study of hepatic arterial infusion chemotherapy for prophylaxis of liver metastases of colorectal cancer after hepatic resection. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(11): 1497-1499, 1995

Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Annals of Surgery 251(4): 686-691, 2010

Treatment of liver metastases from colorectal cancer--major hepatic resection and continuous hepatic arterial infusion chemotherapy. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(4 Pt 2): 777-781, 1990

A pilot study of adjuvant hepatic arterial infusion chemotherapy, associating 5-fluorouracil and leucovorin, after resection of colorectal cancer liver metastases. Surgical Oncology 4(6): 317-322, 1995

Unresectable liver metastases from colorectal cancer and hepatic arterial infusion chemotherapy: how, when and to whom?. Cardiovascular and Interventional Radiology 32(3): 603-604, 2009

Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy. Annals of Surgery 257(1): 114-120, 2013

Hepatic arterial infusion (HAI) for unresectable liver metastases (ULM) from colorectal carcinoma. Tumori 83(1 Suppl): S61, 1997